Monday, 08 August 2022

 

 

LATEST NEWS Fatigue, headache among top symptoms of long Covid Achanta Sharath Kamal wins gold, Sathiyan clinches bronze in men's singles table tennis I played a bit more patiently, that gave me a lot of confidence : Lakshya Sen 'Games of Thrones' star Sean Bean says intimacy coordinators 'spoil the spontaneity' Ankit Tiwari gives another romantic treat to fans with 'Jaaniya' Moeen Ali, Sunil Narine, Chris Lynn, Shimron Hetmyer, Wanindu Hasaranga among big-ticket sign-ons for UAE's ILT20 'Attack on states' authority': Punjab Chief Minister Bhagwant Mann opposes Electricity Amendment Bill Maha cabinet expansion likely on Tuesday, hints Eknath Shinde Aamir Khan hasn't seen SS Rajamouli's magnum opus 'RRR' Lakshya Sen gets India's 20th gold medal after beating Ng Tze Yong in men's singles badminton Previous CMs absence from Niti Aayog meetings harmed state's interests : Malvinder Singh Kang Treatment plants for waste water coming from Rajasthan : Manohar Lal Khattar Google again sues Sonos for copying smart speaker, voice control tech Jennifer Lopez helped resurrect her acting career : Jane Fonda As a batting, bowling team we have a lot to do : Nicholas Pooran Duleep Trophy to kick-start Indian domestic season 2022-23, Irani Cup makes a return Have been an ardent fan of Anurag Kashyap's cinema : Armaan Malik Tried to keep things simple; the talk is to be adaptable : Arshdeep Singh England all-rounder Emma Lamb voted ICC Women's Player of the Month for July Governor Rajendra Vishwanath Arlekar launches 'AYUSH Pathshala Vatika' campaign Governor Rajendra Vishwanath Arlekar inaugurates Apple Fair

 

Indian-American doctor leads mRNA vax trial for pancreatic cancer

Health, Study, New York, Research, Researchers, World News, Pancreatic Cancer, mRNA Vax, Indian American

Web Admin

Web Admin

5 Dariya News

New York , 09 Jun 2022

World's first trial, led by an Indian-American doctor, on a mRNA-based vaccine for pancreatic cancer has shown promise for remission.The new shot is developed by BioNTech based on the same technology used by the German biotech company along with its US partner Pfizer to develop vaccines against Covid-19.

The groundbreaking trial led by Dr Vinod Balachandran at the Memorial Sloan Kettering Cancer Center (MSK) in New York, showed that half of the patients remained cancer-free 18 months after having their tumours removed and receiving the jabs.

The key to these vaccines appears to be proteins in the pancreatic tumours, called neoantigens, which alert the immune system to keep the cancer at bay, according to MSK. The promising results were also presented at the American Society of Clinical Oncology conference in Chicago.

In 8 of 16 patients studied, the vaccines activated T cells that recognise the patient's own pancreatic cancers. These patients also showed delayed recurrence of their pancreatic cancers, suggesting the T cells activated by the vaccines may be having the desired effect to keep pancreatic cancers in check.

According to Balachandran, mRNA vaccines could stimulate the immune system to recognise and attack pancreatic cancer cells."Unlike some of the other immunotherapies, these mRNA vaccines do appear to have the ability to stimulate immune responses in pancreatic cancer patients," Balachandran said of the promising preliminary results.

"So we're very excited about that, and the early results suggest that if you have an immune response, you may have a better outcome."Balachandran added the results should be welcome news for other cancer patients too, as pancreatic cancer has been very difficult to treat with traditional chemotherapies and immunotherapies.

The phase-I trial was also heralded as "encouraging" by BioNTech."We are committed to taking up this challenge by leveraging our long-standing research in cancer vaccinology and are trying to break new ground in the treatment of such hard-to-treat tumours," BioNTech co-founder and chief medical officer Prof Ozlem Tureci said.

A similar trial is also currently underway for bowel cancer and Moderna, another Covid vaccine manufacturer, is also developing mNRA treatments for cancer and autoimmune conditions.

 

Tags: Health , Study , New York , Research , Researchers , World News , Pancreatic Cancer , mRNA Vax , Indian American

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD